Role of aspartate aminotransferase to platelet ratio in the prediction and prognosis of intrahepatic cholestasis of pregnancy: A case–control study from a tertiary center
International Journal of Gynecology & Obstetrics · 2024-02 · 164 (2) · 656-661
DOI: 10.1002/ijgo.15016 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 26.07.2023. Verfasst von Ayça Peker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Perinatology, Department of Obstetrics and Gynecolgy, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Cholestasis, Intrahepatic, Pregnancy Complications. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the aspartate aminotransferase to platelet ratio (APRI) score as a predictive and prognostic test in intrahepatic cholestasis of pregnancy (ICP).
Methods
This study was conducted in 198 patients diagnosed with ICP and 204 healthy pregnant women who presented to a tertiary center between 2019 and 2022. APRI scores; laboratory findings in the first, second, and third trimesters; and perinatal outcomes were compared between the two groups. The ICP group was evaluated for correlation between APRI scores and composite adverse outcomes. Two different receiver operating characteristic analyses were performed to determine optimal cutoff values of predictive APRI score of ICP and composite adverse outcomes in patients with ICP.
Results
Aspartate aminotransferase values and APRI scores were significantly higher in the ICP group in all trimesters ( P < 0.001). The optimal cutoff values of APRI scores to predict ICP for the first, second, and third trimesters were 0.101 (79.7% sensitivity, 79.6% specificity), 0.103 (78.4% sensitivity, 76.3% specificity), and 0.098 (72.5% sensitivity, 72% specificity), respectively. APRI scores were statistically higher in patients with ICP with composite adverse outcomes in all trimesters ( P values of 0.03, 0.04, and 0.01, respectively).
Conclusion
APRI score was found to be a valuable predictor of ICP and its adverse outcomes during the entire pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Perinatology, Department of Obstetrics and Gynecolgy, Turkish Ministry of Health Ankara City Hospital, Ankara, Turkey.
- Division of Perinatology, Department of Obstetrics and Gynecolgy, Turkish Ministry of Health Ankara City Hospital, University of Health Sciences, Ankara, Turkey.
ORCID-Profile: Ayça Peker
Zitieren
APA
Peker, A., Tanaçan, A., İpek, G., Ağaoğlu, Z., & Şahin, D. (2024). Role of aspartate aminotransferase to platelet ratio in the prediction and prognosis of intrahepatic cholestasis of pregnancy: A case–control study from a tertiary center. International Journal of Gynecology & Obstetrics, 164(2), 656-661. https://doi.org/10.1002/ijgo.15016
Vancouver
Peker A, Tanaçan A, İpek G, Ağaoğlu Z, Şahin D. Role of aspartate aminotransferase to platelet ratio in the prediction and prognosis of intrahepatic cholestasis of pregnancy: A case–control study from a tertiary center. International Journal of Gynecology & Obstetrics. 2024;164(2):656-661. doi:10.1002/ijgo.15016
BibTeX
@article{Peker2024,
author = {Peker, Ayça and Tanaçan, Atakan and İpek, Göksun and Ağaoğlu, Zahid and Şahin, Dilek},
title = {Role of aspartate aminotransferase to platelet ratio in the prediction and prognosis of intrahepatic cholestasis of pregnancy: A case–control study from a tertiary center},
journal = {International Journal of Gynecology & Obstetrics},
year = {2024},
volume = {164},
number = {2},
pages = {656--661},
doi = {10.1002/ijgo.15016}
}
EUVIMED